Early safety and efficacy outcomes of the PAUL glaucoma implant in a Spanish population: A retrospective study
The PGI seems to be safe and effective from the early postoperative period. The IOP reduction rate could make it suitable for patients with refractory moderate-to-advanced glaucoma.
Authors
- Elena Millá (ORCID: https://orcid.org/0000-0002-5171-165X)
- Néstor Ventura-Abreu (ORCID: https://orcid.org/0000-0001-5446-7675)
- Sara Labay-Tejado
- Marta Pazos (ORCID: https://orcid.org/0000-0003-4094-6346)
- Marta Muniesa
- Sofía Porto-Castro
- Ainhoa D. Castellarnau
Institutions
- Hospital Clínic de Barcelona (ES)
- Hospital Universitari Sagrat Cor (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Publication Details
- Journal
- Saudi Journal of Ophthalmology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.4103/sjopt.sjopt_164_24
- Citations
- 4
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.15